It targets the receptors of GLP-1 as well as another hormone called glucose-dependent insulinotropic polypeptide (GIP)
The proteins were injected into rabbits to generate polyclonal antibodies according to standard protocols (His-GspD, Cocalico, Reamstown, PA
They suppress appetite, slow gastric emptying (how quickly food leaves your stomach), enhance insulin release when sugar is present, reduce glucagon (a hormone that raises blood sugar), and produce significant weight loss and better blood sugar control in clinical trials
Neurochem 108 , 973985 (2009)
Increasing antipsychotic dose for non response in schizophrenia
Each dose delivers reliable results Made in the USA : Made in FDA-registered facilities with strict quality control at every step Who Should Consider BPC-157 Nasal Spray